CSI Market
Sign In | Register

Regulus Therapeutics Inc (RGLS) Annual Balance Sheets

Annual · GAAP · USD millions
Access RGLS quarterly Balance Sheets →
Examining balance sheet movements between Regulus Therapeutics Inc and Dec 31 2020 reveals how Dec 31 2024 adjusts its asset composition and liability profile.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2024)
(Dec 31 2023) (Dec 31 2022) (Dec 31 2021) (Dec 31 2020)
Assets
Cash & cash equivalent38.53
Short-term Investments, Total37.25
Cash & Short-term Investments75.00
Accounts receivable0.00
Other Current Assets3.08
Prepaid Expense, Current AS3.49
Total Current Assets82.35
Equipment/Property/Plant Net0.94
Intangible Assets0.03
Deferred, Prepaid and Other Assets, Noncurrent0.00
Other Assets, Noncurrent0.00
Restricted Cash0.06
Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization0.00
Operating Lease Right Of Use Asset0.87
Total Assets84.18
Liabilities
Accounts Payable, Current AC0.95
Accrued Liabilities, Current4.64
Debt, Current LI0.00
Other Liabilities, Current1.91
Taxes Payable0.00
Total Current Liabilities7.50
Long-term debt0.00
Total Long-term Debt0.00
Accrued Income Taxes, Noncurrent0.00
Other liabilities, Noncurrent0.27
OperatingLeaseLiabilityNoncurrent0.27
Accrued Research And Development Current0.77
Total Liabilities7.77
Stockholders' Equity
Common Stock Value0.07
Additional Paid In Capital Common Stock635.86
Retained Earnings / Accumulated Deficit-559.57
Other Equity-0.46
Common Stockholder's Equity75.89
Preferred Stockholder's Equity0.51
Total Stockholder's Equity76.41
Liabilities & Stockholder's Equity84.18
4 historic quarters locked

Sign in to unlock the full Regulus Therapeutics Inc balance sheet history.

Sign In Create Free Account

About Regulus Therapeutics Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001628280-25-012627

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.